1. Home
  2. Stock quotes
  3. Vertex Pharmaceuticals Incorporated
  4. Financial Statements
  5. Income Statement
  6. Cost of Revenue
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated VRTX
$ 408.18 0.72%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-05-2024

report update icon

Vertex Pharmaceuticals Incorporated Cost of Revenue 2011-2024 | VRTX

Annual Cost of Revenue Vertex Pharmaceuticals Incorporated

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.26 B 1.08 B 904 M 736 M 548 M 410 M 275 M 210 M - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.26 B 210 M 678 M

Quarterly Cost of Revenue Vertex Pharmaceuticals Incorporated

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
393 M 372 M 343 M - 319 M 309 M 267 M - 289 M 262 M 246 M - 236 M 228 M 192 M 203 M 186 M 185 M 162 M 185 M 132 M 136 M 95.1 M 122 M 111 M 104 M 71.6 M 84.1 M 72.9 M 71.2 M 47 M - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
393 M 47 M 194 M